ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,081 | -98.3% | 789 | -97.0% | 0.00% | – |
| Q2 2023 | $64,026 | +1044.8% | 26,348 | +2613.5% | 0.00% | – |
| Q1 2023 | $5,593 | -99.2% | 971 | -98.8% | 0.00% | -100.0% |
| Q4 2022 | $715,558 | -58.1% | 80,040 | -33.4% | 0.00% | 0.0% |
| Q3 2022 | $1,708,000 | +3613.0% | 120,107 | +3736.1% | 0.00% | – |
| Q2 2022 | $46,000 | +17.9% | 3,131 | +60.6% | 0.00% | – |
| Q1 2022 | $39,000 | -64.5% | 1,950 | -69.0% | 0.00% | – |
| Q4 2021 | $110,000 | +233.3% | 6,291 | +48.3% | 0.00% | – |
| Q3 2021 | $33,000 | +10.0% | 4,243 | +45.2% | 0.00% | – |
| Q2 2021 | $30,000 | -80.4% | 2,923 | -75.0% | 0.00% | – |
| Q1 2021 | $153,000 | -6.1% | 11,688 | +0.9% | 0.00% | – |
| Q4 2020 | $163,000 | +3975.0% | 11,585 | +3698.4% | 0.00% | – |
| Q3 2020 | $4,000 | – | 305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |